News

By Ed Moya US This week Wall Street will learn how quickly the US consumer is weakening and if the…

Intro Relmada Therapeutics (NASDAQ:RLMD) is advancing its NMDA antagonist, REL-1017 (esmethadone), as a novel antidepressant for the treatment of major…

Mind Medicine (NASDAQ:MNMD) has been making great progress lately in advancing the use of a drug in its pipeline known…

Business Model Overview U.S. Physical Therapy (NYSE: NYSE:USPH) operates in two business segments: physical therapy operations and industrial injury prevention…

House Republicans on Friday nominated Rep. Jim Jordan of Ohio as their new nominee for speaker of the House of…

Market Movers rounded up the latest reactions on UnitedHealth Group from investors and analysts. The pros, including Jim Cramer ,…

The more that I have researched the banking industry this year, the more I have come to realize that they…

Transocean (NYSE:RIG) has a strong outlook through the duration of the decade but must prove themselves before shares reflect their…

Pharmacy staff from Walgreens are laying the groundwork for a nationwide walkout and multiple rallies at the end of October…

EHang Holdings Overview When I last covered EHang Holdings Limited (NASDAQ:EH) at the end of 2022, the Chinese autonomous aerial…